3Amster R,Gutman G,Har-Toov J,et al.OC96:The role of ultrasound assessment in the diagnosis of polycystic ovary syndrome(PCOS) according to the 2003 Rotherdam ESHRE/ASRM consensus workshop[J].Ultrasound Obstet Gynecol,2006,28 (4):386-387.
4Kiddg DS,Hamilton-Fairleg D,Bush A,et al.Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome[J].Clin Endocrinol,1992,36(1):105-111.
5Clayton RN,Ogden V,Hodgkinson V,et al.How common are polycystic ovaries in nomal women and what is their significance for the fertility of the population?[J].Clin Endocrinol,1992,37(1):128-134.
6Murphy Mk,Hall JE,Adams JM,et al.Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome[J].J Clin Endocrinol Metab,2006,Aug l;[Epub ahead of print].
7Ehrmann DA,Schneider DJ,Sobel BE,et al.Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism . 1997
8Dunaif A,Scott D,Finegood D,et al.The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism . 1996
9Legro RS,Finegood D,Dunaif A.A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology . 1998
